Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Antibody production industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Process trends
2.1.4 Type trends
2.1.5 End-use trends
Chapter 3 Antibody Production Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising adoption of antibody production for personalized medicine and companion
3.2.1.2 Increasing R&D expenditure in pharmaceutical and biotechnology companies
3.2.1.3 Growing demand for therapeutic antibodies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent government regulations
3.2.2.2 High costs involved in the antibody production
3.3 Growth potential analysis
3.3.1 By process
3.3.2 By type
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Antibody Production Market, By Process, 2018 - 2032 (USD Million)
5.1 Key trends, by process
5.2 Upstream processing
5.2.1 Bioreactors
5.2.2 Consumables
5.3 Downstream processing
5.3.1 Chromatography systems
5.3.2 Chromatography resins
5.4 Filtration
5.4.1 Filtration systems
5.4.2 Filtration consumables & accessories
Chapter 6 Antibody Production Market, By Type, 2018 - 2032 (USD Million)
6.1 Key trends, by type
6.2 Monoclonal antibodies
6.3 Polyclonal antibodies
6.4 Other antibodies
Chapter 7 Antibody Production Market, By End-use, 2018 - 2032 (USD Million)
7.1 Key trends, by end-use
7.2 Pharmaceutical & biotechnology companies
7.3 Diagnostic laboratories
7.4 Research institutes
7.5 Other end-users
Chapter 8 Antibody Production Market, By Region, 2018 - 2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.2 GE Healthcare:
9.3 Merck KGaA
9.4 Sartorius AG
9.5 Eppendorf AG
9.6 Danaher Corporation
9.7 Genetix Biotech Asia Pvt Ltd
9.8 Abcam plc
9.9 FiberCell Systems Inc.
9.10 Bio-Rad Laboratories, Inc.
